Radiopharmaceuticals in prostate cancer - radium-223 episode 1

Episode 1 May 12, 2021 00:30:53
Radiopharmaceuticals in prostate cancer - radium-223 episode 1
COR2ED Medical Education
Radiopharmaceuticals in prostate cancer - radium-223 episode 1

May 12 2021 | 00:30:53


Show Notes

Dr. Tanya Dorff (City of Hope Comprehensive Cancer Center, Los Angeles, USA) and Dr. Phillip Koo (Banner MD Anderson Cancer Center, Arizona, USA) discuss the latest developments in the field of radiopharmaceuticals and their use in Prostate Cancer. They are also joined by guest speaker Dr. Neal Shore (Carolina Urologic Research Center, North Carolina, USA).

In this first episode, the experts focus on the alpha emitter, Radium-223 which received regulatory approval on the basis of the phase 3 ALSYMPCA trial in patients with metastatic castration resistant prostate cancer (mCRPC) and symptomatic bone metastases. They consider mechanism of action and discuss key results from the trial and the safety profile.

The experts also review the ERA-223 and PEACE-III randomised trials which investigated the use of Radium-223 in combination with next generation androgen receptor inhibitors (ARIs). A number of real-world evidence studies are also reviewed as the experts consider where radium-223 fits into the overall treatment sequence for mCRPC patients. Radiation safety and general considerations for delivering therapy with radiopharmaceuticals are also discussed.

Other Episodes

Episode 1

January 30, 2023 00:25:18
Episode Cover

Update from ASCO GI 2023: upper GI cancer highlights

COR2ED Medical Education: This episode, covers the highlights on gastroesophageal, gastric and gastroesophageal junction (GEJ) cancer from ASCO GI 2023.  Dr Nataliya Uboha (University...



December 04, 2023 00:33:58
Episode Cover

Diagnosis and management of short stature patients

Do you know how to differentiate between growth hormone deficiency (or GHD) and primary IGF-I deficiency (or growth hormone resistance) and the key challenges...


Episode 2

September 15, 2022 00:23:01
Episode Cover

ASBMR 2022 Rare Bone Disease Highlights: Episode 3

In this third episode of a three-episode podcast series, COR2ED and ASBMR have partnered with patient advocates Inês Alves (European Rare Bone Forum) and...